Search Results for 'breast her2'
breast her2 published presentations and documents on DocSlides.
HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ
by carny
Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...
Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer
by danika-pritchard
ASCO-CAP Recommendations For HER2 Testing in Brea...
Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings
by marina-yarberry
Management of HER2 Over-Expressed Breast Cancer i...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Metastatic HER2-Positive Breast Cancer: Treatment Selection
by test
First . Line and Beyond. Moderator:. Joseph Gligo...
HER2 TESTING IN BREAST CANCER
by danika-pritchard
Clinical Practice Guideline Update. American Soci...
Metastatic Breast Cancer: A Medical Update
by liane-varnes
Jennifer M. Matro, MD. Rena Rowan Breast Center. ...
Changes in Breast Cancer Reports After Second Opinion
by unita
Dr. Vicente Marco. Department of Pathology. Hospit...
Updates in the Treatment of Breast cancer
by alexa-scheidler
Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...
Pathology of The Breast Lesions of female breast are much more common than lesions of male breast
by PrincessPeach
Most of these lesions are benign. Breast cancer i...
Snyder D, Heidel RE, Panella T, Bell J, Orucevic
by Kingslayer
A. University of Tennessee Medical Center – Knox...
Module 9: HER2-Positive and Triple-Negative BC
by unita
Percent with Patients. Number of Patients (Median)...
2020 Year in Review: Breast Cancer
by caroline
Lisa A. Carey MD, . ScM. University of North Carol...
Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use
by gelbero
Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...
Tumor Marker Phenotype Concordance in Second Primary Breast Cancer
by debby-jeon
Monica Brown, MPH, PhD. . California Cancer Regi...
6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im
by katrgolden
Contents PageIntended Use 4Summary and Explanation...
Denise A. Yardley, MD Sarah Cannon Research Institute
by lily
Senior Investigator, . Breast Cancer Research. Ten...
A case of localized breast cancer
by envrrolex
Antonella Brunello . Kwok-Leung Cheung. Disclosure...
Cutoff value for prominent biomarkers of breast cancer on overall survival using CART analysis
by eddey
Pragya Kumari. 1. , . Atanu. Bhattacharjee. 2. , ...
Understanding Your Diagnosis29 Not all breast cancers are the same
by adia
ere are two separate ideas used when describi...
Use specific response toward environment as a selective marker for therapy in breast cancer cells.
by BraveButterfly
Hsiu. -Ni Kung. Anatomy and Cell Biology, Medical ...
Best practice for chemotherapy for treatment of breast cancer
by ariel
Andreas Makris. Mount Vernon Cancer Center. Royal ...
Neoadjuvant Target Therapy in Her-2 Positive Breast Cancer
by faustina-dinatale
Dr. . Khaled Abulkhair, PhD. Medical Oncology SCE...
RCR breast radiotherapy consensus guidelines
by karlyn-bohler
Producing the guidelines. Draft radiotherapy guid...
Breast Cancer Highlights From San Antonio
by tatyana-admore
Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...
Managing Breast Cancer in the Genomic Era
by alida-meadow
Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...
Chemotherapeutic Treatment Options for Triple Negative Breast Cancer
by iris
Lauren Barney. April 17, 2013. Breast Cancer Subty...
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
by calandra-battersby
An Interactive Oncology Grand Rounds Series. Joyc...
